
FDA OKs New Test to Match Lung Cancer Patients With Targeted Therapies
The U.S. Food and Drug Administration (FDA) has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy (sunvozertinib), according to a news release from Thermo Fisher Scientific. This …